Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and Infectious Diseases, Honorary and NHMRC Career Development Fellow
MBBS (Hons) DCH FRACP FRCPA PhD
Dr Chris Blyth is a clinical academic and NHMRC Career Development Fellow. He is Associate Professor of Paediatrics with the School of Medicine, University of Western Australia (UWA) and Research Fellow with Wesfarmers Centre for Vaccines and Infectious Diseases (WCVID; Telethon Kids Institute [TKI], WA). He leads the Department of Paediatric Infectious Diseases at Princess Margaret Hospital (PMH) and a Clinical Microbiologist with PathWest Laboratory. In 2017, he was the top ranked applicant in the TKI Supporting Research Leaders Scheme.
He has more than a fifteen years of experience in conducting clinical paediatric and infectious diseases research focusing on questions relevant to public policy and clinical practice. The majority of his research is in influenza, vaccine-preventable respiratory tract infection, pneumonia, respiratory co-infection, emerging respiratory pathogens and vaccine safety. His PhD (Preventing influenza morbidity in Australian children through vaccination; 2016) evaluated the WA preschool influenza vaccination program and has been instrumental in influencing national influenza policy. He holds a NHMRC Career Development Fellowship (2016-2019: Evaluation and optimisation of paediatric vaccination programs in Australia and the region) which is evaluating influenza and pneumococcal vaccination programs in Australia and PNG. In 2017 he returned from a post-doctoral fellowship with the Center for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia and University of Pennsylvania.
He leads research groups undertaking hospital-based clinical research focusing on severe paediatric infections, vaccine preventable diseases and vaccine safety in Western Australia and Eastern Highlands Province, Papua New Guinea. He collaborates broadly with other research groups within WCVID, TKI, Princess Margaret Hospital and other Australian paediatric tertiary hospitals. He was appointed as a sitting member of ATAGI, Australia’s peak immunisation advisory group to Government in 2012 and assumed the role of deputy chair in 2014. In addition, he is chair of the ATAGI Pneumococcal Working Party and ATAGI/CNDA Rabies Working Party. Both working parties are currently undertaking extensive revisions of national pneumococcal and rabies prevention strategies.